JAK-STAT Signalling Pathway
In this video we the JAK STAT Signalling pathway has been discussed.
The JAK-STAT Pathway is mediated via Cytokine signals. The JAK comes from Janus Kinase , where as the STAT is the Signal Transducer and Activator of Transcription.
The JAK-STAT signaling pathway transmits information from extracellular chemical signals to the nucleus resulting in DNA transcription and expression of genes involved in immunity, proliferation, differentiation, apoptosis and oncogenesis. The JAK-STAT signalling cascade consists of three main components: a cell surface receptor, a Janus kinase (JAK) and two Signal Transducer and Activator of Transcription (STAT) proteins. Disrupted or dysregulated JAK-STAT functionality can result in immune deficiency syndromes and cancers.
The binding of various ligands, usually cytokines, such as interferon, interleukin, and growth factors to cell surface receptors, activate associated JAKs, increasing their kinase activity.Activated JAKs then phosphorylate tyrosine residues on the receptor, creating binding sites for proteins possessing SH2 domains. SH2 domain containing STATs are recruited to the receptor where they are also tyrosine-phosphorylated by JAKs. These activated STATs form hetero- or homodimers and translocate to the cell nucleus where they induce transcription of target genes. STATs may also be tyrosine-phosphorylated directly by receptor tyrosine kinases, such as the epidermal growth factor receptor, as well as by non-receptor (cytoplasmic) tyrosine kinases such as c-src.
The pathway is negatively regulated on multiple levels. Protein tyrosine phosphatases remove phosphates from cytokine receptors and activated STATs. More recently identified suppressors of cytokine signaling (SOCS) inhibit STAT phosphorylation by binding and inhibiting JAKs or competing with STATs for phosphotyrosine binding sites on cytokine receptors.[4] STATs are also negatively regulated by protein inhibitors of activated STAT (PIAS), which act in the nucleus through several mechanisms.[5] For example, PIAS1 and PIAS3 inhibit transcriptional activation by STAT1 and STAT3, respectively by binding and blocking access to the DNA sequences they recognize.
Видео JAK-STAT Signalling Pathway канала Hussain Biology
The JAK-STAT Pathway is mediated via Cytokine signals. The JAK comes from Janus Kinase , where as the STAT is the Signal Transducer and Activator of Transcription.
The JAK-STAT signaling pathway transmits information from extracellular chemical signals to the nucleus resulting in DNA transcription and expression of genes involved in immunity, proliferation, differentiation, apoptosis and oncogenesis. The JAK-STAT signalling cascade consists of three main components: a cell surface receptor, a Janus kinase (JAK) and two Signal Transducer and Activator of Transcription (STAT) proteins. Disrupted or dysregulated JAK-STAT functionality can result in immune deficiency syndromes and cancers.
The binding of various ligands, usually cytokines, such as interferon, interleukin, and growth factors to cell surface receptors, activate associated JAKs, increasing their kinase activity.Activated JAKs then phosphorylate tyrosine residues on the receptor, creating binding sites for proteins possessing SH2 domains. SH2 domain containing STATs are recruited to the receptor where they are also tyrosine-phosphorylated by JAKs. These activated STATs form hetero- or homodimers and translocate to the cell nucleus where they induce transcription of target genes. STATs may also be tyrosine-phosphorylated directly by receptor tyrosine kinases, such as the epidermal growth factor receptor, as well as by non-receptor (cytoplasmic) tyrosine kinases such as c-src.
The pathway is negatively regulated on multiple levels. Protein tyrosine phosphatases remove phosphates from cytokine receptors and activated STATs. More recently identified suppressors of cytokine signaling (SOCS) inhibit STAT phosphorylation by binding and inhibiting JAKs or competing with STATs for phosphotyrosine binding sites on cytokine receptors.[4] STATs are also negatively regulated by protein inhibitors of activated STAT (PIAS), which act in the nucleus through several mechanisms.[5] For example, PIAS1 and PIAS3 inhibit transcriptional activation by STAT1 and STAT3, respectively by binding and blocking access to the DNA sequences they recognize.
Видео JAK-STAT Signalling Pathway канала Hussain Biology
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
![Components of JAK-STAT Pathway | JANUS KINASE & STAT](https://i.ytimg.com/vi/7g-ZczJ6eJM/default.jpg)
![Common cell signaling pathway](https://i.ytimg.com/vi/9sF_h-bAnIE/default.jpg)
![Receptor Tyrosine Kinase | RTK Signalling](https://i.ytimg.com/vi/0mKZRAt0GZg/default.jpg)
![Mechanism of Action of JAK Inhibitors](https://i.ytimg.com/vi/dnnsqiDjAgM/default.jpg)
![TGF Beta Signalling Pathway](https://i.ytimg.com/vi/TfPHZqT7b9A/default.jpg)
![Endocrinology | Receptor Pathways](https://i.ytimg.com/vi/RMV130vU8gA/default.jpg)
![Receptors & Intra-cellular Signalling - Made Easy](https://i.ytimg.com/vi/4PfYqWiV0w0/default.jpg)
![NF-κB Pathway | Cell Survival Pathway](https://i.ytimg.com/vi/8HWVhdSRvng/default.jpg)
![Endocrinology | Growth Hormone](https://i.ytimg.com/vi/_LKdNhF2WhI/default.jpg)
![JAK STAT pathway | short tricks to learn fast](https://i.ytimg.com/vi/AremP-_ow5w/default.jpg)
![Wnt/β-Catenin Signaling Pathway | Overview, Purpose and APC Mutations](https://i.ytimg.com/vi/NGVP4J9jpgs/default.jpg)
![The JAK/STAT pathway](https://i.ytimg.com/vi/qpnP8lSjxa0/default.jpg)
![JAK STAT Signaling Pathway: Regulation](https://i.ytimg.com/vi/U5xkeBpV04g/default.jpg)
![Cytokines : Structure ,sub families ,signaling mechanism and biomedical use](https://i.ytimg.com/vi/G8k17APYSv8/default.jpg)
![Leptin Function, Signaling via the LepR, & Overall Physiological Effects](https://i.ytimg.com/vi/oPoN-SJrAKw/default.jpg)
![JAK-STAT Signaling Pathway](https://i.ytimg.com/vi/8uxTTucIb48/default.jpg)
![Receptor Tyrosine Kinases - RTK](https://i.ytimg.com/vi/44iGSUrJYr8/default.jpg)
![What are Protein Kinases? Mechanism of action and it's Types CSIR NET JRF|ICMR DBT|GATE.](https://i.ytimg.com/vi/yFcCNt4ofSM/default.jpg)
![mapk pathway](https://i.ytimg.com/vi/HGb4M1RBObE/default.jpg)
![T Cell Activation | Mechanism](https://i.ytimg.com/vi/tOBAWMV_pbg/default.jpg)